Clinical Trial Update: Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating low-dose colchicine for arterial inflammation in patients with diabetes and vascular events; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Diabetes Mellitus

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Cardiovascular Diseases, Atherosclerosis | Phase 3 | Status: RECRUITING